Unique ID issued by UMIN | UMIN000038988 |
---|---|
Receipt number | R000044460 |
Scientific Title | Study on the utility of the short wavelength cut filter attached to the UVA 1(340~400nm) phototherapy device for Cutaneous T-cell Lymphomas. |
Date of disclosure of the study information | 2019/12/28 |
Last modified on | 2020/06/26 08:53:20 |
Study on the utility of the short wavelength cut filter attached to the UVA 1(340~400nm) phototherapy device for Cutaneous T-cell Lymphomas.
Study on the utility of the short wavelength cut filter attached to the phototherapy device for CTCL.
Study on the utility of the short wavelength cut filter attached to the UVA 1(340~400nm) phototherapy device for Cutaneous T-cell Lymphomas.
Study on the utility of the short wavelength cut filter attached to the UVA 1(340~400nm) phototherapy device for CTCL.
Japan |
Cutaneous T-Cell Lymphomas
Dermatology |
Malignancy
NO
To evaluate the efficacy of the short wavelength cut filter attached to the UVA 1(340~400nm) phototherapy device for Cutaneous T-Cell Lymphomas.
Safety,Efficacy
skin pigmentation of irradiation area
Interventional
Parallel
Non-randomized
Open -no one is blinded
Active
2
Treatment
Device,equipment |
attached the short wavelength cut filter
not attached the short wavelength cut filter
16 | years-old | <= |
65 | years-old | > |
Male and Female
1 Cutaneous T-cell Lymphomas patients who are candidates for phototherapy.
2 Age between 16 and 65,written approval of patient. If the patient is a minor, the consent is needed from both the patient and the legal representative.
3 Patients who can understand the study and can issue consent to the study in writing.
1 Patient who is not candidates for phototherapy.
- Patient who will activate or recur malignant skin tumors.
- Patient who has high carcinogenic risk(xeroderma pigmentosum, radiation therapy, internal use or touching career of arsenic etc.)
- Patient who has remarkable photodermatosis(hereditary photodermatosis, albinism, porphyria, photosensitive collagen disease etc.)
2 Patient who participated other clinical studies or trials within 3 months of this study entry.
3 Pregnant or possibly pregnant women, or breastfeeding women. Women who wish to become pregnant during study participation.
4 Patient who is judged inappropriate to participate in the study by the investigator.
10
1st name | Akimichi |
Middle name | |
Last name | Morita |
Nagoya City University Graduate School of Medical Sciences
Department of Geriatric and Environmental Dermatology
4678601
1-Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya, Aichi
052-853-8261
amorita@med.nagoya-cu.ac.jp
1st name | Akimichi |
Middle name | |
Last name | Morita |
Nagoya City University Graduate School of Medical Sciences
Department of Geriatric and Environmental Dermatology
4678601
1-Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya, Aichi
052-853-8261
amorita@med.nagoya-cu.ac.jp
Nagoya City University Graduate School of Medical Sciences
Department of Geriatric and Environmental Dermatology
USHIO INC.
Profit organization
Nagoya City University Graduate School of Medical Sciences and Nagoya City University Hospital Institutional Review Board
1-Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya, Aichi
0528587215
clinical_research@med.nagoya-cu.ac.jp
NO
2019 | Year | 12 | Month | 28 | Day |
Unpublished
Open public recruiting
2019 | Year | 12 | Month | 09 | Day |
2019 | Year | 12 | Month | 09 | Day |
2019 | Year | 12 | Month | 09 | Day |
2020 | Year | 12 | Month | 31 | Day |
2019 | Year | 12 | Month | 25 | Day |
2020 | Year | 06 | Month | 26 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000044460